Search

Your search keyword '"Nortriptyline adverse effects"' showing total 331 results

Search Constraints

Start Over You searched for: Descriptor "Nortriptyline adverse effects" Remove constraint Descriptor: "Nortriptyline adverse effects"
331 results on '"Nortriptyline adverse effects"'

Search Results

1. Efficacy and safety of cytisine versus nortriptyline for smoking cessation: A multicentre, randomized, double-blinded and placebo-controlled trial.

2. Efficacy and safety of venlafaxine versus nortriptyline for the preventive treatment of migraine: A double-blind randomized clinical trial.

Catalog

Books, media, physical & digital resources

3. Adverse drug events associated with nortriptyline compared with paroxetine and alternative medications in an older adult population: a retrospective cohort study in Southern California.

4. Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.

5. ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY.

6. Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation.

7. Antidepressants for smoking cessation.

8. Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram.

9. Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.

10. Risk of cardiovascular events according to the tricyclic antidepressant dosage in patients with chronic pain: a retrospective cohort study.

11. Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Controlled Trial.

12. The Effectiveness of Nortriptyline and Tolerability of Side Effects in Neurogenic Cough Patients.

13. Delayed Cardiotoxicity From a Massive Nortriptyline Overdose Requiring Prolonged Treatment.

14. Brugada Phenocopy: A Case of Incessant Ventricular Tachycardia in a Patient with Tricyclic Antidepressant Overdose.

15. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.

16. Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.

17. Nortriptyline Abuse: A Case Report and Review of the Literature.

18. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.

19. Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial.

20. A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy.

21. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

22. Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial.

23. Combination of morphine with nortriptyline for neuropathic pain.

24. Exploring the role of drug-metabolising enzymes in antidepressant side effects.

25. Melatonin Interaction Resulting in Severe Sedation.

26. Epidural steroid injections, conservative treatment, or combination treatment for cervical radicular pain: a multicenter, randomized, comparative-effectiveness study.

27. Transcranial magnetic stimulation as an antidepressant alternative in a patient with Brugada syndrome and recurrent syncope.

28. [Efficacy and safety of medication use for the cessation of tobacco addiction: A review of Clinical Practice Guidelines].

29. An electronic health records study of long-term weight gain following antidepressant use.

30. Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval.

31. Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction.

32. Equivalency of tricyclic antidepressants in open-label neuropathic pain study.

33. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.

34. Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.

35. Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community.

36. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.

37. SSRIs: a premature burial.

38. Response to "SSRIs: a premature burial".

39. Electrocardiographic changes upon tricyclic antidepressant administration mimicking Brugada syndrome.

40. Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial.

41. Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.

42. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.

43. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders.

44. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

45. Effects of nortriptyline on QT prolongation: a safety pharmacology study.

46. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.

47. Variation in GNB3 predicts response and adverse reactions to antidepressants.

48. Changes in body weight during pharmacological treatment of depression.

49. Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis.

50. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.